KR20040035769A - 안구 감염을 치료하기 위한 일부 옥사졸리디논 예를 들어리네졸리드의 전신적 투여 - Google Patents

안구 감염을 치료하기 위한 일부 옥사졸리디논 예를 들어리네졸리드의 전신적 투여 Download PDF

Info

Publication number
KR20040035769A
KR20040035769A KR10-2004-7003679A KR20047003679A KR20040035769A KR 20040035769 A KR20040035769 A KR 20040035769A KR 20047003679 A KR20047003679 A KR 20047003679A KR 20040035769 A KR20040035769 A KR 20040035769A
Authority
KR
South Korea
Prior art keywords
formula
compound
mixture
pharmaceutically acceptable
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7003679A
Other languages
English (en)
Korean (ko)
Inventor
제이 그렉 슬래터
Original Assignee
파마시아 앤드 업존 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파마시아 앤드 업존 캄파니 filed Critical 파마시아 앤드 업존 캄파니
Publication of KR20040035769A publication Critical patent/KR20040035769A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR10-2004-7003679A 2001-09-14 2002-09-11 안구 감염을 치료하기 위한 일부 옥사졸리디논 예를 들어리네졸리드의 전신적 투여 Ceased KR20040035769A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32215301P 2001-09-14 2001-09-14
US32211501P 2001-09-14 2001-09-14
US60/322,153 2001-09-14
US60/322,115 2001-09-14
PCT/US2002/025977 WO2003024528A1 (en) 2001-09-14 2002-09-11 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections

Publications (1)

Publication Number Publication Date
KR20040035769A true KR20040035769A (ko) 2004-04-29

Family

ID=26983274

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7003679A Ceased KR20040035769A (ko) 2001-09-14 2002-09-11 안구 감염을 치료하기 위한 일부 옥사졸리디논 예를 들어리네졸리드의 전신적 투여

Country Status (12)

Country Link
US (2) US20030069235A1 (https=)
EP (1) EP1425068A1 (https=)
JP (1) JP2005507884A (https=)
KR (1) KR20040035769A (https=)
CN (1) CN1281211C (https=)
BR (1) BR0212466A (https=)
CA (1) CA2460360A1 (https=)
IL (1) IL160490A0 (https=)
MX (1) MXPA04002071A (https=)
NZ (1) NZ531353A (https=)
PL (1) PL370033A1 (https=)
WO (1) WO2003024528A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108283622A (zh) * 2018-04-03 2018-07-17 广州君博医药科技有限公司 一种缓释型利奈唑胺眼用药物及其制备方法
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1305374A (zh) * 1998-07-14 2001-07-25 法玛西雅厄普约翰美国公司 治疗眼部感染的噁唑烷酮
ATE337002T1 (de) * 1999-09-13 2006-09-15 Insite Vision Inc Topische behandlung zur vorbeugung von augeninfektionen
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares

Also Published As

Publication number Publication date
WO2003024528A1 (en) 2003-03-27
US20030069235A1 (en) 2003-04-10
CA2460360A1 (en) 2003-03-27
IL160490A0 (en) 2004-07-25
MXPA04002071A (es) 2005-02-17
NZ531353A (en) 2006-09-29
CN1545428A (zh) 2004-11-10
US20050234052A1 (en) 2005-10-20
HK1068564A1 (en) 2005-04-29
CN1281211C (zh) 2006-10-25
EP1425068A1 (en) 2004-06-09
PL370033A1 (en) 2005-05-16
BR0212466A (pt) 2004-10-19
JP2005507884A (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
US5811446A (en) Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
ZA200506531B (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CA2900372A1 (en) Methods of treating topical microbial infections
CN1222287C (zh) 含有佐米曲普坦的药用制剂
JPH08505868A (ja) クラブラン酸のみまたは他のベータ−ラクタム抗生物質と混合されたクラブラン酸からなる薬剤処方
US10045940B2 (en) Composition comprising an antibiotic and a corticosteroid
US20190105320A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20200289466A1 (en) Methods and uses of nampt activators for treatment of diabetes, cardiovascular diseases, and symptoms thereof
EP2260870A2 (en) Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
CN106146558A (zh) 新的噁唑烷酮类化合物及其制备方法
KR20040035769A (ko) 안구 감염을 치료하기 위한 일부 옥사졸리디논 예를 들어리네졸리드의 전신적 투여
CA2962655C (en) A combination of kynurenine and antigen presenting cells (apc) as therapeutics and methods for their use in immune modulation
EA016274B1 (ru) Применение янтарной кислоты для профилактики и лечения нейродегенеративных заболеваний
AU2002341559A1 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
ZA200401995B (en) Treatment for ocular infections.
US7153826B2 (en) Treatment of rosacea
HK1068564B (en) The use of oxazolidones substance in the preparation of a medicament for treating ophthalmic infection in mammal
CN111757732A (zh) 用于治疗感染性动脉疾病和相关病状的组合物
CN121925262A (zh) 多黏菌素b/甲氧苄啶与利福平的增强型制剂及其眼部应用方法
EA048481B1 (ru) Лекарственное средство и его применение для лечения бактериальных инфекций, связанных с биопленкой
WO2020117497A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
WO2014164526A1 (en) Oxamazin antibiotics
WO2005074898A2 (en) Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
KR20060120204A (ko) 삼출성 중이염의 예방 및/또는 치료제

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040312

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070911

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090730

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20091229

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20090730

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I